Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.12M Buy
+22,652
New +$4.8M 1.09% 21
2026
Q1
$4.17M Buy
22,737
+4,604
+25% +$848K 0.3% 71
2025
Q4
$3.19M Buy
18,133
+21
+0.1% +$3.43K 0.23% 79
2025
Q3
$2.54M Sell
18,112
-11
-0.1% -$1.49K 0.33% 60
2025
Q2
$2.28M Buy
18,123
+288
+2% +$35.9K 0.18% 102
2025
Q1
$2.44M Buy
17,835
+3,903
+28% +$558K 0.35% 58
2024
Q4
$2.13M Sell
13,932
-7
-0.1% -$1.18K 0.19% 92
2024
Q3
$2.7M Sell
13,939
-17
-0.1% -$3.56K 0.25% 69
2024
Q2
$3.24M Buy
13,956
+104
+0.8% +$22.6K 0.33% 56
2024
Q1
$2.99M Buy
13,852
+5,098
+58% +$1.19M 0.31% 59
2023
Q4
$2.26M Buy
+8,754
New +$2.15M 0.23% 75

Other funds holding BIIB

Leo Wealth's BIIB Position: Q3 2026 in Review

Leo Wealth opened a new position in Biogen (BIIB) in Q3 2026: 22,652 shares worth $5.12M. The stake represents 1.09% of the portfolio and ranks #21 among its holdings. This is a return to the name: Leo Wealth previously reported a position in BIIB as recently as Q1 2026.

Leo Wealth first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Leo Wealth held 22,652 shares of Biogen worth $5.12M as of Q3 2026.
  • Biogen was a new Leo Wealth position in Q3 2026.
  • Biogen made up 1.09% of Leo Wealth's portfolio in Q3 2026, its #21 holding.
  • Leo Wealth first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Leo Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.